Leonard Hayflick has been unafraid to speak his mind, whether it is to upend a well-entrenched dogma or to challenge the federal government. At 86, he’s nowhere near retirement.

Ned Shaw US scientists have reason to feel both heady and scared. The federal government recently released unprecedented billions of dollars to fund bioterrorism research. Yet, the merits of this sudden shift in focus are being debated, and some worry that the money will be squandered or wasted. "I have been really very upset by the focus on bioterrorism," says Stanley Falkow, professor of microbiology and immunology and of medicine at Stanford University. "Everybody's talking about it, but th

Find the latest updates in this one-stop resource, including efficacy data and side effects of approved shots, as well as progress on new candidates entering human studies.

Critics Charge Author: FRANKLIN HOKE, pp.1 Date: July 11,1994 Disputing what they see as unproductive preoccupation with HIV-specific studies, they step up campaign for a `wider window' of research Progress in AIDS research has faltered in the United States since the mid-1980s, according to some scientists, owing to a premature narrowing of the research focus by the scientific and administrative leadership of the National Inst

Critics Charge Author: FRANKLIN HOKE, pp.1 Date: July 11,1994 Disputing what they see as unproductive preoccupation with HIV-specific studies, they step up campaign for a `wider window' of research Progress in AIDS research has faltered in the United States since the mid-1980s, according to some scientists, owing to a premature narrowing of the research focus by the scientific and administrative leadership of the National Inst